4.6 Article

Immune profile alterations of systemic lupus erythematosus patients with infections

Related references

Note: Only part of the references are listed.
Review Rheumatology

Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets

Mary K. Crow

Summary: Research has identified type I interferon (IFN-I) and autoantibodies targeting nucleic acids and nucleic acid-binding proteins as fundamental contributors to the pathogenesis of systemic lupus erythematosus (SLE). This review summarizes recent genetic analyses of SLE patients and current studies on innate and adaptive immune function, which contribute to sustained IFN-I pathway activation, immune activation, autoantibody production, inflammatory mediator generation, and tissue damage. The goal of these studies is to understand disease mechanisms, identify therapeutic targets, and develop better treatments for patients.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Immunology

Cytokine Expression of Lung Bacterial Infection in Newly Diagnosed Adult Hematological Malignancies

Zengzheng Li et al.

Summary: In adult patients newly diagnosed with hematological malignancies, elevated levels of IL-6, IL-8, and IL-10 were associated with lung bacterial infections. Monitoring the abnormal increase of IL-6, IL-8, and IL-10 can help in predicting bacterial infections in the lungs of these patients.

FRONTIERS IN IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms

Sujin Kang et al.

Summary: Interleukin-6 (IL-6) plays a key role in inflammation, and blocking its signaling can help in the treatment of various chronic inflammatory diseases. Tocilizumab, an antibody to the IL-6 receptor, has shown therapeutic potential in conditions like rheumatoid arthritis and juvenile systemic idiopathic arthritis.

EXPERIMENTAL AND MOLECULAR MEDICINE (2021)

Review Immunology

The Neutrophil

Garth Lawrence Burn et al.

Summary: Neutrophils are immune cells with potent antimicrobial properties, capable of efficiently killing microorganisms both intracellularly and extracellularly. In addition to fighting infections, they can use their toxic machinery in other contexts such as cancer. However, inappropriate or dysregulated activation of neutrophils can lead to host damage and contribute to autoimmune and inflammatory diseases.

IMMUNITY (2021)

Review Immunology

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

Filippo Veglia et al.

Summary: MDSCs are pathologically activated cells with potent immunosuppressive activity, closely associated with poor clinical outcomes in diseases like cancer. Recent studies have identified key distinctions between MDSCs and classical neutrophils and monocytes, providing new insights into therapeutic targeting for cancer and autoimmune diseases through understanding their genomic and metabolic characteristics. Emerging data also suggest potential involvement of MDSCs in pregnancy, neonatal biology, and COVID-19.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Immunology

Autoimmunity and organ damage in systemic lupus erythematosus

George C. Tsokos

NATURE IMMUNOLOGY (2020)

Letter Dermatology

Expansion of Myeloid-Derived Suppressor Cells in the Peripheral Blood and Lesional Skin of Cutaneous Lupus Patients

Stephanie Florez-Pollack et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)

Review Medicine, General & Internal

Novel paradigms in systemic lupus erythematosus

Thomas Doerner et al.

LANCET (2019)

Review Rheumatology

The role of IL-6 in host defence against infections: immunobiology and clinical implications

Stefan Rose-John et al.

NATURE REVIEWS RHEUMATOLOGY (2017)

Article Medicine, General & Internal

Systemic lupus erythematosus

Arvind Kaul et al.

NATURE REVIEWS DISEASE PRIMERS (2016)

Review Immunology

IL-6 as a keystone cytokine in health and disease

Christopher A. Hunter et al.

NATURE IMMUNOLOGY (2015)

Article Multidisciplinary Sciences

Altered T Lymphocyte Proliferation upon Lipopolysaccharide Challenge Ex Vivo

Fanny Poujol et al.

PLOS ONE (2015)

Article Medicine, General & Internal

Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study

J. Merayo-Chalico et al.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2013)

Article Immunology

White Blood Cell Count Abnormalities and Infections in One-year Follow-up of 124 Patients with SLE

Ana Margarida Brito Dias et al.

CONTEMPORARY CHALLENGES IN AUTOIMMUNITY (2009)

Article Rheumatology

Predictors of major infections in systemic lupus erythematosus

Guillermo Ruiz-Irastorza et al.

ARTHRITIS RESEARCH & THERAPY (2009)

Review Biochemistry & Molecular Biology

Cytokines in Mycoplasma pneumoniae infections

J Yang et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2004)